GLOW

Research · BPC + GHK-Cu + TB-500

Overview

BPC + GHK-Cu + TB-500 is a research combination of three independently studied compounds. BPC-157 is a synthetic 15-residue sequence derived from a protein fraction originally isolated from human gastric juice. GHK-Cu is the copper(II) complex of the endogenous Gly-His-Lys sequence, first identified in human plasma. TB-500 is a synthetic analog derived from thymosin beta-4, a 43-residue actin-sequestering protein expressed in most nucleated cells, and is commonly described as incorporating its actin-binding region. The blend is supplied for laboratory investigation of tissue-repair, angiogenesis, and cell-migration pathways.

Mechanism of action

Each component acts through a distinct pathway. BPC-157 has been reported to interact with the nitric oxide system and to modulate VEGFR2 expression and FAK-paxillin signaling in endothelial and fibroblast models. GHK-Cu binds copper(II) with high affinity and is proposed to act as a copper-delivery and signaling complex, with gene-expression analyses indicating modulation of transcripts governing extracellular matrix synthesis and remodeling. Thymosin beta-4 sequesters monomeric G-actin, regulating cytoskeletal dynamics and cell motility, and has been shown to form a complex with PINCH and integrin-linked kinase, activating Akt survival signaling in cardiac and endothelial cells.

Key research findings

1. 01

   Preclinical rodent studies of BPC-157 characterize effects on angiogenesis, vascular collateral recruitment, and tissue-repair endpoints in gastrointestinal, tendon, and vascular injury models.

2. 02

   In vitro and gene-expression studies of GHK-Cu document modulation of collagen and glycosaminoglycan synthesis and broad shifts in transcript profiles in human cell lines.

3. 03

   Murine myocardial infarction studies of thymosin beta-4 (2004) characterized integrin-linked kinase activation, cardiomyocyte migration and survival, and effects on cardiac function endpoints.

4. 04

   The combination itself has not been characterized as a single entity in peer-reviewed studies; available data derive from investigations of each component individually.

Published references

• BPC 157 and blood vessels

  Seiwerth S et al. — Curr Pharm Des, 2014 · PMID: 23782145

• GHK and DNA: resetting the human genome to health

  Pickart L et al. — Biomed Res Int, 2014 · PMID: 25302294

• Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair

  Bock-Marquette I et al. — Nature, 2004 · PMID: 15565145

The information above is derived from published preclinical and clinical research. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.